The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index; 13 of the 17 sources its claims cite were checked for support.
Combined Transcriptome and Metabolome Analysis Reveals That the Potent Antifungal Pyrylium Salt Inhibits Mitochondrial Complex I in Candida albicans
Open accessAbstract
Transcriptome and metabolome analysis showed that the antifungal compound xy12 inhibits mitochondrial complex I in Candida albicans.
Overview
CoChat Summary
TL;DR
The pyrylium salt derivative xy12 has stronger anti-*Candida albicans* activity than SM21 and acts by inhibiting mitochondrial complex I, disrupting oxidative phosphorylation and ATP production. Integrated transcriptome and metabolome analyses plus mitochondrial mutant and biochemical assays support complex I as a key antifungal target.
Key findings
- xy12 had MIC90 values of 0.125–0.25 μg/mL against *C. albicans* isolates, about 2-fold lower than SM21, including against fluconazole-resistant clinical isolates. It inhibited hypha formation and biofilm formation dose-dependently; 1 μg/mL inhibited about 30%–40% of biofilm, and 2 or 4 μg/mL reduced biofilm to about 15%.
- RNA-seq identified 1,826 upregulated and 1,628 downregulated genes; metabolomics identified 1,197 metabolites and 260 differential metabolites. Integrated KEGG analysis highlighted oxidative phosphorylation and carbon-source metabolism, with downregulation of mitochondrial complex I–V genes and accumulation of TCA intermediates such as succinate and fumarate.
- Mitochondrial complex I–deficient mutants (nue1Δ/Δ, nue2Δ/Δ, nuo3Δ/Δ, nuo4Δ/Δ) showed decreased sensitivity to 0.5 μg/mL xy12, whereas complex III– and IV–deficient mutants showed increased sensitivity. Rotenone antagonized xy12, increasing MIC90 from 0.25 to 0.5 and 1 μg/mL; carboxin was synergistic, reducing MIC90 to 0.125 or 0.0313 μg/mL.
- xy12 reduced mitochondrial complex I activity by about 30% at 0.5 μg/mL and about 50% at 1 μg/mL, decreased intracellular ATP at 2 or 4 μg/mL, reduced mitochondrial membrane potential, caused mtDNA loss, impaired mitochondrial morphology, and decreased cell wall N-linked mannoproteins.
Methods
- *C. albicans* SC5314, clinical isolates, and mitochondrial complex–deficient mutants were tested by MIC, disk diffusion, time-growth/time-kill, hypha, biofilm (XTT and crystal violet), spot, and checkerboard assays.
- RNA-seq was performed on DMSO- or 2 μg/mL xy12-treated SC5314 for 3 h; DEGs were defined as P < 0.05 and |log2-fold change| ≥ 1, with GO/KEGG enrichment. Untargeted metabolomics used UHPLC-QTOF-MS after 2 μg/mL xy12 treatment for 8 h; differential metabolites were defined by OPLS-DA VIP > 1 and P < 0.05.
- Follow-up assays included RT-qPCR, mitochondrial complex I activity measurement, ATP quantification, JC-1 mitochondrial membrane potential, MitoTracker/Tom70p-GFP microscopy, Alcian blue and ConA-FITC cell wall staining, and growth on fermentable versus nonfermentable carbon sources.
Limitations
- The paper states that direct binding of xy12 to mitochondrial complex I was not studied in depth, and future work is needed to identify interacting subunits and NADH/coenzyme Q effects. It also states that whether xy12 affects mitochondrial fusion or division was not determined.
- The paper notes that hypha and biofilm inhibition occurred at higher concentrations than the MIC90, so it is difficult to conclude whether those effects are due to disrupted mitochondrial function or simply inhibition of proliferation. It also notes that xy12-treated cells still grew slowly on nonfermentable carbon sources, suggesting other antifungal mechanisms are involved.
- The paper states that HPLC-MS rather than GC-MS was used, so identified metabolites were dominated by highly polar compounds and lipid-related pathways were less enriched. The text makes evident that this study reports in vitro experiments; in vivo efficacy is cited from prior work rather than demonstrated here.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![FIG 2 The compound xy12 inhibited growth and hypha and biofilm formation in C. albicans. (A) Time-growth curves. C. albicans SC5314 was treated with 1, 2, or 4 μg/mL of xy12 for 24 h and the OD600 (optical density at 600 nm) was measured at the indicated time points. (B) Time-kill curves of xy12 against C. albicans. C. albicans SC5314 was incubated with different concentrations of xy12 for 6 or 12 h in RPMI 1640 or YPD medium and plated on Sabouraud dextrose agar to count the living clones. (C) Hypha formation. C. albicans SC5314 was adjusted to 3 × 105 cells/mL in Spider or RPMI 1640 medium with or without the indicated concentrations of xy12 and cultured at 37°C for 3 h. (D) Biofilm formation detected by XTT [2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide] reduction. Biofilms of C. albicans SC5314 with or without xy12 treatment were induced in RPMI 1640 medium at 37°C for 24 h. XTT/menadione was added to the wells and the absorbance of supernatant was measured at 490 nm. ***, P < 0.001, unpaired t test. (E) Biofilm formation stained by crystal violet. The biofilms were stained with 0.4% crystal violet and quantified. (F) The coated cells were photographed.](https://figures.cochat.ai/paper-figures/2d1be6c22e104e20b19bdfa57de9e2a0/combined-transcriptome-and-metabolome-analysis-reveals-that-the-potent-figure-2.jpg)







Verification
Claims the paper makes
10 Valid · 2 Not valid · 4 Not checked · 102 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“The MIC90 of SM21 against C. albicans increased 2-fold in medium supplied with peptone (30).”
§ Combined Transcriptome and Metabolome Analysis Reveals That the Potent Antifungal Pyrylium Salt Inhibits Mitochondrial Complex I in Candida albicans > DISCUSSION
What the sources say
- Supportedcites [30] Truong T, Suriyanarayanan T, Zeng G, Le TD, Liu L, Li J, Tong C, Wang Y, Seneviratne CJ. 2018. Use of haploid model of Candida albicans to uncover mechanism of action of a novel antifungal agent. Front Cell Infect Microbiol 8: 164. doi: 10.3389/fcimb.2018.00164. 29938200 PMC6002804 source
The Results section, “Exploring the role of amino acid supplements in SM21 resistance,” reports that peptone supplementation raised the SM21 MIC90 from 1 to 2 μg/ml in the tested wild-type C. albicans strains. It also reports a rise from 4 to 8 μg/ml in resistant strains—both twofold increases. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Mitochondrial complex mutants display deficiencies in growth, carbon source utilization, cell membrane and cell wall composition, yeast-to-hyphae transformation, biofilm formation, antifungal sensitivity, and interactions with host cells (24, 34).”
§ Combined Transcriptome and Metabolome Analysis Reveals That the Potent Antifungal Pyrylium Salt Inhibits Mitochondrial Complex I in Candida albicans > DISCUSSION
What the sources say
- Partly supportedcites [24] Li D, She X, Calderone R. 2016. Functional diversity of complex I subunits in Candida albicans mitochondria. Curr Genet 62: 87– 95. doi: 10.1007/s00294-015-0518-6. 26373419 PMC4724564 sourceExperimental — accuracy not yet measured
Section 2.3 (page unavailable) reports impaired growth on glycerol in most complex I mutants, fluconazole hypersusceptibility, cell-wall defects, altered membrane-related activity, and reduced host-tissue colonization or epithelial-cell binding in specified mutants. It does not establish that these mutants have deficiencies in yeast-to-hyphae transformation or biofilm formation; it says biofilm studies of their fluconazole sensitivity are still needed. (LLM, conf=0.86)
- Partly supportedcites [34] Li S-X, Song Y-J, Zhang Y-S, Wu H-T, Guo H, Zhu K-J, Li D-M, Zhang H. 2017. Mitochondrial complex V α subunit is critical for Candida albicans pathogenicity through modulating multiple virulence properties. Front Microbiol 8: 285. doi: 10.3389/fmicb.2017.00285. 28280492 PMC5322696 sourceExperimental — accuracy not yet measured
The Results report that the C. albicans ATP1 mutant has impaired growth on non-glucose carbon sources, defective filamentation and biofilm formation, and impaired host-cell interactions. The stress-response Results report altered membrane-stress and antifungal responses, but do not establish a deficiency in cell membrane or cell wall composition; the mutant was resistant to fluconazole rather than more sensitive to it. No page numbers are available in our copy. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“As shown in Fig. 9B, treatment with xy12 led to sparser fibrils compared to those in normal cells, as observed by transmission electron microscopy, which is consistent with the requirement of mitochondrial complex I for cell wall integrity (25).”
§ Combined Transcriptome and Metabolome Analysis Reveals That the Potent Antifungal Pyrylium Salt Inhibits Mitochondrial Complex I in Candida albicans > RESULTS > Carbon source utilization and cell wall N-linked mannoprotein biosynthesis in C. albicans was inhibited by compound xy12.
What the sources say
- Supportedcites [25] She X, Calderone R, Kruppa M, Lowman D, Williams D, Zhang L, Gao Y, Khamooshi K, Liu W, Li D. 2016. Cell wall N-linked mannoprotein biosynthesis requires Goa1p, a putative regulator of mitochondrial complex I in Candida albicans. PLoS One 11: e0147175. doi: 10.1371/journal.pone.0147175. 26809064 PMC4725855 source
The citation supports the background point that mitochondrial complex I function is linked to cell-wall formation, not the citing authors’ own observation about xy12. In the Results (page unavailable), TEM showed fewer and shorter outer-wall fibrils in GOA31 than in wild-type cells; the Discussion identifies Goa1p as a putative complex I regulator and links its function to cell-wall synthesis. This paper does not report an xy12 treatment. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“which was more obvious than the effect of peptone found by Wong et al. (16).”
§ Combined Transcriptome and Metabolome Analysis Reveals That the Potent Antifungal Pyrylium Salt Inhibits Mitochondrial Complex I in Candida albicans > DISCUSSION
What the sources say
- Could not verifycites [16] Wong SSW, Kao RYT, Yuen KY, Wang Y, Yang D, Samaranayake LP, Seneviratne CJ. 2014. In vitro and in vivo activity of a novel antifungal small molecule against Candida infections. PLoS One 9: e85836. doi: 10.1371/journal.pone.0085836. 24465737 PMC3899067 sourceExperimental — accuracy not yet measured
The Materials and Methods section (Broth dilution assay; page unavailable) describes MIC testing in RPMI 1640 medium, and the Results section (SM21 is active against fungi but not bacteria; page unavailable) lists MICs by fungal strain. Neither reports an effect of peptone on MIC. Searches for “peptone” and for MIC changes with nonfermenting carbon sources found no passage addressing the attributed comparison. (LLM, conf=0.76)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the analysis of molecular function and cellular composition, proton transmembrane transporter activity, NADH dehydrogenase activity, proton-transporting ATP synthase complex, and respiratory chain complexes were significantly enriched (Fig. S1).”
§ Combined Transcriptome and Metabolome Analysis Reveals That the Potent Antifungal Pyrylium Salt Inhibits Mitochondrial Complex I in Candida albicans > RESULTS > Compound xy12 negatively regulated the expression of genes involved in mitochondrial oxidative phosphorylation.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
87 more claims
Create a free account to see all 118 claims and every source verdict.
- Probably not a substantial claim. 8
- It may state two separate claims as one. 20
Citations
Cites
Co-infections in people with COVID-19: a systematic review and meta-analysis.
Lansbury, L., Lim, B., Baskaran, V., & Lim, W. S. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.046 · Cited by 1,619 · cited 1×
“(4) showed that the most common COVID-19-associated fungal infections are caused by C.”
BackgroundNolfi-Donegan, D., Braganza, A., & Shiva, S. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101674 · Cited by 1,488 · cited 1×
“The process of oxidative phosphorylation is accompanied by electron transport via the ETC, located in the inner mitochondrial membrane (19).”
BackgroundKullberg, B. J., & Arendrup, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1315399 · Cited by 1,315 · cited 1×
“C andida, Aspergillus, and Cryptococcus are the main opportunistic pathogens that cause invasive fungal infections in immunocompromised patients (1, 2).”
BackgroundTackling the emerging threat of antifungal resistance to human health
Fisher, M. C., Alastruey-Izquierdo, A., Berman, J., Bicanic, T., Bignell, E. M., Bowyer, P., Bromley, M., Brüggemann, R., Garber, G., Cornely, O. A., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00720-1 · Cited by 1,179 · cited 1×
“Although current antifungal agents can cure most fungal infections, increasing resistance to azoles and echinocandins, the high toxicity of polyenes, and the poor oral bioavailability of polyenes and echinocandins have increased the need for novel antifungal compounds (6, 7).”
BackgroundAntifungal Susceptibility Testing: Current Approaches
Berkow, E. L., Lockhart, S. R., & Ostrosky-Zeichner, L. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00069-19 · Cited by 368 · cited 1×
“albicans were determined by the microdilution method as described by the Clinical and Laboratory Standards Institute (M27-A3) with a few modifications (37).”
MethodImmune defence to invasive fungal infections: A comprehensive review
Pathakumari, B., Liang, G., & Liu, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110550 · Cited by 264 · cited 3×
“The relative expression of each gene was calculated by the threshold cycle (2) method.”
BackgroundMethodMerz, S., & Westermann, B. (2009) · Genome Biology · doi:10.1186/gb-2009-10-9-r95 · Cited by 213
Shingu-Vazquez, M., & Traven, A. (2011) · Eukaryotic Cell · doi:10.1128/ec.05184-11 · Cited by 209 · cited 1×
“As the powerhouse of eukaryotic cells, mitochondria are vital for energy metabolism, including anabolic and catabolic processes: for example, energy production, carbon, nitrogen, lipid, and iron metabolism, and the synthesis of amino acids, nucleic acids, and phospholipids (8).”
BackgroundInvasive fungal disease in humans: are we aware of the real impact?
Firacative, C. (2020) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760200430 · Cited by 184 · cited 1×
“which is comparable to the number of deaths caused by tuberculosis (3).”
BackgroundAntifungal Resistance: a Concerning Trend for the Present and Future
Hendrickson, J. A., Hu, C., Aitken, S. L., & Beyda, N. (2019) · Current Infectious Disease Reports · doi:10.1007/s11908-019-0702-9 · Cited by 139 · cited 1×
“Although current antifungal agents can cure most fungal infections, increasing resistance to azoles and echinocandins, the high toxicity of polyenes, and the poor oral bioavailability of polyenes and echinocandins have increased the need for novel antifungal compounds (6, 7).”
Background
Cited by
Discovery of New Antimicrobial Metabolites in the Coculture of Medicinal Mushrooms
Ji, L., Tan, L., Shang, Z., Li, W., Mo, X., Yang, S., & Yu, G. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c09476 · Cited by 18
Cao, L., Tan, J., Zhang, Z., Lin, B., Mu, Y., Jiang, M., Jiang, Y., Huang, X., & Han, L. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c08707 · Cited by 9
Self-citation(2024) · doi:10.1128/spectrum.02594-23 · Cited by 10
Xu, D., Niu, Q., Gao, L., et al. (2024) · Food Control · doi:10.1016/j.foodcont.2024.110956 · Cited by 6
Self-citationZhang, Q., Li, G., Wang, Y., Yang, C., Bai, W., Li, Q., Zhang, J., & Zhang, P. (2025) · Microorganisms · doi:10.3390/microorganisms13030683 · Cited by 2
Metadata
- Authors
- Lv, Q., Yan, L., Wang, J., Feng, J., Gao, L., Qiu, L., Chao, W., Qin, Y.-L., & Jiang, Y.
- Affiliations
- Second Military Medical University (CN)
- Tongji University (CN)
- Fudan University Minhang Hospital, Shanghai, People’s Republic of China
- Corresponding author
- Jiang, Yuanying
- Venue
- Microbiology Spectrum
- Publisher
- American Society for Microbiology
- Published
- 2023-04-13
- Volume
- 11
- Issue
- 2
- Pages
- e0320922-e0320922
- ISSN
- 2165-0497 (ISSN-L)
- PMC
- PMC10100848
- OpenAlex
- W4320856057
- Semantic Scholar
- aebce1fbc4adb0e111dbeef280c13fb734a9e666
- Cited by
- 12
- References
- 44
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 4
- FWCI
- 2.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Microbiology Spectrum (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- MOST | National Key Research and Development Program of China (2021YFC2300400)
- National Natural Science Foundation of China (81902039, 82020108032, 82173867)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- Candida albicans, antifungal agents, mitochondrial complex I inhibition, transcriptome, metabolome, antifungal resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Combined Transcriptome and Metabolome Analysis Reveals That the Potent Antifungal Pyrylium Salt Inhibits Mitochondrial Complex I in Candida albicans. https://app.cochat.ai/papers/10.1128/spectrum.03209-22
- The paper
- Lv, Q., Yan, L., Wang, J., Feng, J., Gao, L., Qiu, L., Chao, W., Qin, Y.-L., & Jiang, Y. (2023). Combined Transcriptome and Metabolome Analysis Reveals That the Potent Antifungal Pyrylium Salt Inhibits Mitochondrial Complex I in Candida albicans. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03209-22
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.